Molecule uses hormones to fight diabetes

Share this article:

A team of researchers say a two-hormone approach to type 2 diabetes appears to reduce sugar levels as well as chip away at obesity. The experimental two-in-one combination fuses a GLP-1 and a gastric inhibitory peptide. Digestive processes naturally trigger these two hormones. Researchers say their simulation maximizes the metabolic impact of these hormones which also influence appetite and fat burning. The study incorporated data from Roche and was published in Science Translational Medicine.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

DOJ closes Brilinta investigation

AstraZeneca announced the end of the investigation Tuesday.

Doctors back unique biosimilar names

A host of doctors has asked FDA Commissioner Margaret Hamburg to back a naming convention that would require biologics and biosimilars to have different names.

Roche has no rights to Sovaldi, panel rules

Despite a collaboration with original Sovaldi owner Pharmasset in 2004, a panel ruled Roche has no rights to HCV treatment Sovaldi.